Zinc sulfate therapy for infertile male with or without varicocelectomy.

One hundred one men were treated for infertility with 440 mg of zinc sulfate daily for sixty days to two years. All subjects demonstrated low seminal plasma zinc concentrations prior to treatment. Patients were divided into two groups: group [Zn], 65 subjects who underwent zinc therapy alone and group [Var/Zn], 36 subjects who received zinc sulfate therapy after varicocelectomy. In both groups seminal zinc levels were significantly higher (P less than 0.05 and P less than 0.01, respectively) two months after the initiation of zinc therapy. There were no significant changes in sperm count or motility for the [Zn] patients. However, group [Var/Zn] showed a significant increase (P less than 0.05) of sperm motility at two months and twelve months after starting zinc sulfate therapy. We separated the [Var/Zn] patients into two sub-divisions: those who impregnated their wives after therapy, and those who remained infertile despite treatment. Only those patients who impregnated their wives showed a significant (P less than 0.05) increase in sperm motility two months after the initiation of zinc therapy. Those patients of the [Var/Zn] group who remained infertile despite treatment showed a significant increase (P less than 0.05) in sperm motility after twelve months of therapy. Of the [Zn] patients 27.7 per cent (18) successfully impregnated their wives, while the [Var/Zn] patients exhibited a pregnancy rate of 50 per cent (18 patients). These data indicate that zinc sulfate therapy for patients with low seminal zinc concentrations may be an effective treatment for infertile patients especially after varicocelectomy.

Effect of low-dose androgen and zinc sulfate on sperm motility and seminal zinc levels in infertile men.

Beneficial effects of zinc therapy in some infertile patients with low seminal zinc concentrations and decreased sperm motility have been reported recently. The effects of zinc therapy, low-dose (5-10 mg/day) androgen therapy, and combination therapy of both zinc and low-dose androgen, on sperm motility and seminal zinc concentration were studied in patients referred to the andrology clinic. Low-dose androgen therapy increased seminal zinc concentrations and sperm motility, only when pretreatment seminal zinc concentrations were low. Furthermore, patients with low seminal zinc concentrations and poor sperm motility showed greater improvement of sperm motility and seminal zinc levels in response to zinc sulfate with fluoxymesterone than did fluoxymesterone alone or zinc sulfate alone, possible due to a synergistic effect of zinc and androgen.

Effect of sympathetic denervation of rat internal genitalia on daily sperm output.

Using the technique of vasocystostomy, daily sperm output was determined in rats undergoing surgical removal of the sympathetic nerves to the internal genitalia. Between ten and fourteen days after denervation, the daily sperm output significantly (p less than 0.001) decreased below presurgical rates and those of sham-operated control animals (p less than 0.01). This change occurred without changes in plasma testosterone concentration or testicular histology. These data suggest neural control of sperm transport in the rat.

Prostaglandins in semen and their relationship to male fertility: a study of 145 men.

Prostaglandin (PG) F2 alpha and PGE were measured in 163 semen samples from 145 men attending our male infertility clinic. In addition, each semen sample was analyzed for 13 different fertility parameters. Blood plasma levels of testosterone, follicle-stimulating hormone, and luteinizing hormone were also determined in many of the patients. The data obtained were then analyzed using multiple regression analyses on each PG for all of the parameters studied. The results indicate seminal PGF2 alpha and PGE concentrations were 2.78 +/- 0.24 micrograms/ml and 46.0 +/- 4.5 micrograms/ml, respectively. The seminal parameters that were significant predictors of seminal PGF2 alpha included: Ca++ concentration (P less than 0.001), Zn++ concentration (P less than 0.01), and percentage of tapered sperm (P less than 0.05). The seminal parameters that were significant predictors of seminal PGE included: Ca++ concentration (P less than 0.01) and sperm motility (P less than 0.05). Plasma testosterone was also a significant predictor of seminal PGE (P less than 0.05). These results suggest that seminal PGs are important to the human male fertility potential in that their levels are significantly interdependent with specific parameters of male fertility.

Significance of testicular size measurement in andrology. I. A new orchiometer and its clinical application.

When performing a physical examination in the andrology clinic, accurate measurement of testicular size is important. Two methods for measuring testicular size have been developed using calipers for measurement and comparison with plastic testicular models. We have developed a new orchiometer, which consists of a graded series of punched-out elliptical rings with the volume of the ellipsoids indicated on each ring. Testicular sizes measured by our orchiometer had a better correlation with real testicular size determined by water displacement of testes after castration when compared with those data obtained by using calipers. By the use of this orchiometer, the normal range of the adult testicular size was greater than 14 ml in Japan and greater than 17 ml in the United States. This orchiometer is valuable for the rapid and accurate assessment of sexual maturation in children and men.

Regulation of rat caput epididymidis contractility by prostaglandins.

Mechanical activity of the rat caput epididymidis in vitro was recorded using a videomicrography system. The effects of prostaglandin (PG)F2 alpha, PGE2, and aspirin on caput epididymidis contractility were determined by measuring the frequency of contraction, luminal diameter, and amplitude of contraction at various concentrations of each test compound in vitro. PGF2 alpha stimulated contractility of the tubules at physiological concentrations, while PGE2 reduced contractility. Aspirin strongly inhibited contractility at concentrations of 10(-3) and 10(-2)M. Endogenous levels of PGF2 alpha and PGE were determined for rat testes, caput, corpus, and cauda epididymidis and vas deferens. While the concentrations of PGE were consistently higher than those of PGF2 alpha, both compounds were relatively low in the testes, high in the vas deferens, and intermediate throughout the epididymis. Results from these experiments strongly suggest that PGs are important regulators of proximal epididymidis contractions and thus may regulate sperm transport through that organ.

The effect of prepubertal spermatic cord torsion on subsequent fertility in rats.

This study was undertaken to determine the effects of various durations of testicular torsion in prepubertal rats on their subsequent fertility, and to determine whether these effects could be altered by removal of the torsioned testis. Sixty rats (35 days old) were subjected to 720 degrees unilateral spermatic cord torsion for 0, 1, 3, 5, 9, or 12 hours. The torsioned testis was then either detorsioned or removed. At 65 days of age each male was housed with two females for three weeks. Rats undergoing detorsion of the spermatic cord demonstrated a linear decrease in fertility with respect to the duration of torsion (r = -0.904). However, all of the animals undergoing unilateral torsion with subsequent orchiectomy were fertile, regardless of the duration of torsion. In addition, the percentage of females impregnated, the number of embryos produced, and the mean embryo size decreased with increasing intervals of torsion (r = -0.834 to r = -0.979); the sharpest decline occurred between 5 and 9 hours of torsion. All of these parameters were significantly lower (P less than 0.001 to P less than 0.05) in the detorsioned group as compared to the orchiectomized group. There was a decrease in seminiferous tubule diameter in the contralateral testis with respect to the duration of torsion (P less than 0.01). These data indicate that unilateral spermatic cord torsion in young rats significantly reduced their subsequent fertility with respect to duration of the torsion, and that this detrimental effect may be minimized if the damaged testis is removed rather than untwisted and replaced into the scrotum.

Spermatic cord torsion: effects of cyclosporine and prednisone on fertility and the contralateral testis in the rat.

Unilateral spermatic cord torsion results in contralateral degeneration and reduced fertility in the prepubertal male rat. This study was conducted to investigate the use of immunosuppression with cyclosporine and prednisone to prevent these untoward effects. Thirty-five-day-old male rats were subjected to 720 degrees unilateral spermatic cord torsion of 9 hours duration. At the time of detorsion, animals were given a subcutaneous injection of i) cyclosporine, ii) prednisone, or iii) cyclosporine combined with prednisone. Control groups included: i) animals undergoing orchiectomy of the ipsilateral testis following the torsion period, ii) hemicastration in the absence of torsion and iii) sham surgery. Orchiectomy at the end of the torsion period prevented the torsion induced reduction of fertility, contralateral seminiferous tubule diameter and testis weight. Treatment with cyclosporine combined with prednisone significantly increased these parameters above detorsion alone. These data indicate that short term immunosuppression with cyclosporine alone or in combination with prednisone limits the adverse effects of unilateral spermatic cord torsion as does removal of the damaged organ at the end of the torsion period.

Histopathology of prepubertal rat testes subjected to various durations of spermatic cord torsion.

Sixty prepubertal rats were subjected to unilateral spermatic cord torsion for a duration of 0, 1, 3, 5, 9 or 12 hours. At the end of this period, the ipsilateral testes either were removed for immediate processing or subjected to detorsion and orchiopexy, followed by a six-week recovery period prior to histologic study. Twelve histologic parameters were each scored according to the degree of pathologic findings, thus allowing for a quantitative assessment of testicular damage. The sequence of specific histologic degeneration that occurred with spermatic cord torsion is described. These changes were found to be dependent on the duration of torsion, with the greatest damage occurring after three hours or more. In the animals undergoing detorsion followed by a six-week recovery period, severe degeneration was noted for all durations of torsion studied. The extent of this degeneration was significantly correlated with a reduction in fertility.

Spermatic cord torsion. Contralateral testicular degeneration at various ages in the rat.

Unilateral spermatic cord torsion causes damage to the contralateral testis in humans and animals models. It is now known, however, at what age an animal's reproductive capacity is most susceptible to this type of trauma. To determine if the animal's age is a factor in its susceptibility to reproductive damage, rats at 30 to 70 days of age were subjected to unilateral spermatic cord torsion. Rats of the same ages underwent sham surgery and served as controls. The animals were allowed to recover from the surgery and to attain puberty before a period of fertility testing. Fertility, serum testosterone, organ weight, and testicular histologic data were obtained after the breeding period. Our data indicate that animals undergoing torsion at the youngest (30 days) and oldest (70 days) ages exhibited no change in the parameters studied. Animals between the ages of 35 and 50 days are highly susceptible to reproductive damage due to unilateral spermatic cord torsion, and the 35-day-old animals exhibit the most susceptibility. The stages of testicular development occurring during this period are such that damage to one testicle will result in degeneration of both organs. However, once the animal is older than 50 days, its reproductive capacity is not affected by spermatic cord torsion. The specific period of susceptibility in the development of human testes is yet to be defined.

The effect of ketoconazole on endocrine and reproductive parameters in male mice and rats.

Ketoconazole has been shown to reduce steroidogenesis by inhibiting the cytochrome P-450 enzymes in these pathways. This finding, along with the observation that the compound reduces sperm motility, led us to study the effectiveness of ketoconazole as a male contraceptive agent administered in acute and chronic studies of both rats and mice. Four hours after a single administration, male rats showed significant reductions in both serum testosterone and corticosterone levels that completely recovered (testosterone) or nearly recovered (corticosterone) 24 hours after administration. Chronic administration of ketoconazole to male rats and mice resulted in steroid levels comparable with those of control animals. Epididymal sperm motility was only slightly reduced in male mice 4 hours after administration of the drug. No effect on sperm motility was noted after chronic administration in either species studied. In vitro exposure of epididymal sperm to ketoconazole resulted in a significant reduction of sperm motility. Breeding trials after ketoconazole administration resulted in normal fertility and fecundity even at the highest dosage studied. The lack of correlation between steroid levels and sperm immobilization, along with rapid in vivo and in vitro effects on sperm motility, suggests that the reduction in sperm motility is not related to a decrease in steroid levels. From these data, the authors conclude that ketoconazole is probably not a viable approach to the development of a male contraceptive.

Smoothness of ablation on acrylic by four different excimer lasers.

PURPOSE: There are many different excimer laser devices available for photoablative refractive surgery. Smoothness of ablation may vary with different excimer lasers systems. METHODS: Ablations were performed on polymethylmethacrylate (PMMA) plates of 8 x 4 x 0.5 cm, with four different excimer lasers: VISX-Star, Coherent Schwind Keratom I/II, Chiron Technolas Keracor 117C (Plano Scan), and the Nidek EC-5000, to determine and compare the homogeneity and smoothness of the surface. Ten -3.00 D samples, ten -6.00 D samples, and ten -9.00 D samples were ablated with each laser. The PMMA discs were examined with optical microscopy, documented by photographs, and each sample was measured quantitatively using a Hommel-Werkel rugosimeter. We used the same PMMA material throughout. RESULTS: Statistically significant differences in smoothness were found between the Chiron Technolas 117C and the VISX-Star, Nidek and VISX-Star, and Coherent Schwind and VISX-Star in the homogeneities achieved by ablating -3.00 D. Ablations of -6.00 D resulted in homogeneities that were statistically significantly different: Chiron Technolas 117C with the other three devices, the Nidek EC-5000 with the VISX-Star, and the Coherent-Schwind with the VISX-Star. In the ablations for -9.00 D, statistically significant differences in homogeneity were found between the Chiron Technolas 117C and Nidek, between the Chiron and VISX-Star, between the Coherent Schwind and VISX-Star, and between the Nidek and VISX-Star. The laser with the scanning spot system was smoother. CONCLUSION: Scanning spot technology produced smooth ablations even up to -9.00 D.

Laser in situ keratomileusis for hyperopia.

PURPOSE: To evaluate the results of laser in situ keratomileusis (LASIK) to treat hyperopia. SETTING: Instituto de la Vision, Buenos Aires, Argentina. METHODS: This nonrandomized study comprised 679 eyes of 321 patients having LASIK. Patients were divided into three groups based on preoperative spherical equivalent: Group A (low hyperopia, 2.00 diopters [D] or less); Group B (moderate hyperopia, between 2.00 and 3.00 D); Group C (high hyperopia, more than 3.00 D). The following were measured postoperatively: uncorrected visual acuity (UCVA); best spectacle-corrected visual acuity (BSCVA); refraction (evolution and distribution); lines of visual acuity gained and lost. Follow-up was 1 month in 79.4% of cases, 3 months in 75.5%, 6 months in 68.5% and 1 year in 38.3%. RESULTS: Six months after LASIK. 100% of cases in Group A, 95.3% in Group B, and 71.4% in Group C were within +/- 1.00 D of emmetropia; UCVA was 20/40 or better in 94.1, 100, and 87.8%, respectively. The percentage losing or gaining 0 +/- 1 line of BSCVA was 100, 97.6, and 100, respectively. CONCLUSIONS: Laser in situ keratomileusis was predictable and safe in the treatment of low and moderate hyperopia.

Comparison of optical zones in hyperopic laser in situ keratomileusis: 5.9 mm versus smaller optical zones.

PURPOSE: To compare the results of hyperopic laser in situ keratomileusis (LASIK) with a 5.9 mm optical zone (OZ) with those with smaller zones (4.4 to 5.5 mm). SETTING: Instituto de la Visión, Buenos Aires, Argentina. METHODS: The results of LASIK with a 5.9 mm OZ (147 cases) were compared with those in a previously reported group treated with OZs of 4.4 to 5.5 mm (679 cases). In the 5.9 mm group, 31.3% (46 eyes) had low hyperopia, 46.9% (69 eyes) had moderate hyperopia, and 21.8% (32 eyes) had high hyperopia. In the smaller OZ group, follow-up was 1 month in 79.4% (539 eyes), 3 months in 75.5% (501 eyes), 6 months in 68.5% (465 eyes), and 1 year in 38.3% (260 eyes). The hyperopic population studied was divided into 3 subgroups based on the preoperative spherical equivalents of the manifest refraction: subgroup A, low hyperopia: < or = +2.0 diopters (D); subgroup B, moderate hyperopia: +2.0 to +3.0 D; and subgroup C, high hyperopia: > +3.0 D. The following parameters were measured postoperatively: uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), refraction (evolution and distribution), and visual acuity lines gained and lost. RESULTS: The preoperative mean spherical equivalents in the 5.9 mm OZ group were +1.47 +/- 0.41 (SD) (subgroup A); +2.98 +/- 0.41 (subgroup B); and +5.13 +/- 0.61 (subgroup C). In the smaller OZ group, they were +1.31 +/- 0.74, +2.56 +/- 0.28, and +5.28 +/- 0. 69, respectively. At 12 months, the distribution of eyes in the 5.9 mm OZ group with refractions within +/-1.0 D were as follows: subgroup A, 100%; subgroup B, 100%; and subgroup C, 94.2%. In the smaller OZ group, the distributions were 100%, 95.3%, and 71.4%. In the 5.9 mm and the smaller OZ groups, the UCVA was 20/40 or better in 92.0% and 81.8% of eyes, respectively, in subgroup A; 94.6% and 100%, respectively, in subgroup B; and 76.5% and 77.9%, respectively, in subgroup C. The percentage of eyes with 0 +/- 1 line of BCVA 12 months after the procedure was also determined in the 5.9 mm OZ group and compared with the percentages in the smaller OZ group. CONCLUSION: Results of hyperopic LASIK with a 5.9 mm OZ in eyes with low, moderate, and high hyperopia are more stable, predictable, and safe than those in eyes with OZs smaller than 5.9 mm.

Customized ablation for asymmetrical corneal astigmatism.

PURPOSE: To evaluate laser in situ keratomileusis (LASIK) cases in which a customized ablation assisted by corneal topography was performed. SETTING: Instituto de la Visión, Buenos Aires, Argentina. METHODS: The study group comprised 23 cases with asymmetrical corneas; 17 had myopia and 6, hyperopia. Visual acuity, spherical equivalent (SE), and cylinder vectorial change measurements, along with keratometry and corneal topography, were performed in all cases preoperatively and postoperatively. RESULTS: In the myopic cases, the mean preoperative SE was -4.92 diopters (D) +/- 2.46 (SD); it was -0.38 +/- 0.66 D after a mean follow-up of 4.41 +/- 2.32 months. In the hyperopic cases, the preoperative SE was +3.54 +/- 1.57 D; it was +0.33 +/- 0.50 D after a mean follow-up of 3.42 +/- 3.23 months. Cylinder vectorial change, visual acuity, and the number of visual acuity lines gained or lost were also evaluated in both groups. CONCLUSION: Although some features of our algorithm for corneal-topography-assisted customized ablations should be modified, the results of our treatment of cases with asymmetrical astigmatism were encouraging.

Treatment of hyperopic astigmatism.

PURPOSE: To analyze the results after laser-assisted in situ keratomileusis (LASIK) treatment for positive cylinder at the flattest meridian. SETTING: Instituto de la Visión, Buenos Aires, Argentina. METHODS: A prospective, nonrandomized study was conducted. Patients were divided into three groups: (1) simple hyperopic astigmatism (SHA); 15 eyes with a mean preoperative cylinder of +3.37 diopters (D) +/- 1.62 (SD); compound hyperopic astigmatism (CHA); 75 eyes with a mean preoperative cylinder of +3.34 +/- 1.39 D; (3) mixed astigmatism (MA); 73 eyes with a mean preoperative cylinder of +3.45 +/- 2.15 D. In all eyes, treatment of the cylinder was performed at the flattest meridian by LASIK using the Chiron-Technolas Keracor 116/117 laser. The following parameters were analyzed over time: uncorrected visual acuity; best corrected visual acuity; correction of the spherical equivalent and the cylinder; lines of visual acuity gained and lost. RESULTS: Six months after the procedure, refractive cylinder was reduced to +0.58 +/- 1.22 D in the SHA group, +0.12 +/- 1.23 D in the CHA group, and -0.11 +/- 1.28 D in the MA group. Uncorrected visual acuities were 20/20 or 20/25 in 66.7, 60.4, and 76.5% of the groups, respectively. CONCLUSIONS: Use of the LASIK technique with the Keracor laser to treat positive cylinder at the flattest meridian corrected simple and compound hyperopic astigmatism and mixed astigmatism with good predictability and safety. This treatment has not produced a hyperopic refractive change at the opposite meridian.

Contrast sensitivity assessment using the visual performance tester.

The visual performance tester (VPT), a device that uses patient response time as a variable to assess visual power, is described. Results in 126 emmetropic eyes that had not had surgery are presented. The VPT provides more complete and accurate information about visual performance than the standard visual acuity examination because the device considers all variables involved in visual function results.

Laser in situ keratomileusis versus arcuate keratotomy to treat astigmatism.

PURPOSE: To analyze the effectiveness of laser in situ keratomileusis (LASIK) and arcuate keratotomy (AK) to treat simple myopic, compound myopic, and mixed astigmatism. SETTING: Instituto de la Visión, Buenos Aires, Argentina. METHODS: This retrospective nonrandomized study comprised 821 cases treated with LASIK and 46 cases treated with AK. Patients were divided into 4 groups, which had the following preoperative cylinder corrections: simple myopic astigmatism (Group 1) (LASIK: n = 76, -3.91 diopters [D] +/- 1.29 [SD]; AK: n = 5, -3.85 +/- 0.65 D); compound myopic astigmatism up to 2.00 D (Group 2) (LASIK: n = 401, -1.69 +/- 0.76 D; AK: n = 14, -1.48 +/- 0.41 D); compound myopic astigmatism over 2.00 D (Group 3) (LASIK: n = 253, -3.61 +/- 0.89 D; AK: n = 16, -3.09 +/- 0.84 D); mixed astigmatism (Group 4) (LASIK: n = 91, +3.65 +/- 1.62 D; AK: n = 11, 4.39 +/- 0.92 D). RESULTS: Six months postoperatively, the cylinder's vector-corrected change was as follows: Group 1, LASIK 3.75 +/- 1.08 D, AK 3.16 +/- 0.84 D; Group 2, LASIK 1.55 +/- 1.12 D, AK 1.34 +/- 0.44 D; Group 3, LASIK 3.39 +/- 0.98 D, AK 2.70 +/- 1.21 D; Group 4, LASIK 3.77 +/- 1.43 D, AK 3.75 +/- 0.89 D. Respective mean uncorrected visual acuities in each group were as follows: Group 1, 0.71 +/- 0.12 and 0.60 +/- 0.12; Group 2, 0.83 +/- 0.12 and 0.78 +/- 0.24; Group 3, 0.78 +/- 0.18 and 0.48 +/- 0.24; Group 4, 0.69 +/- 0.21 and 0.55 +/- 0.18. CONCLUSIONS: The vector-corrected change and visual acuity achieved with LASIK were better, although not significantly, than those attained with AK except for the UCVA obtained with LASIK in eyes with compound myopic astigmatism over 2.00 D. Both methods proved to be safe.

Corneal ectasia after laser in situ keratomileusis.

PURPOSE: To describe 7 patients who developed ectasia following laser in situ kerato-mileusis (LASIK). SETTING: Instituto de la Visión, Buenos Aires, Argentina. METHODS: In this retrospective study of 7 patients, visual acuity, refraction, pachymetry, and corneal topography were examined before and after the refractive procedure and the occurrence of ectasia. RESULTS: Two of the 7 patients required penetrating keratoplasty. Ectasia developed within a mean of 1.02 years +/- 0.31 (SD). The clinical evolution of ectasia and the potential physiopathogenic causes of ectasia are described. CONCLUSION: Ectasia should be considered a potential complication of LASIK that is closely related to corneal thickness, but another variable, the optical zone diameter, should also be considered.